Results 291 to 300 of about 365,877 (337)

Cardiac surveillance in immune checkpoint inhibitor therapy: Insights from the Essen Cardio‐oncology Registry

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Immune checkpoint inhibitors (ICI) have revolutionized cancer therapy, offering improvements in survival across various malignancies. However, their toxicities pose a major challenge for cardio‐oncology units. Despite their growing importance, data on effectiveness of such specialized units in mitigating ICI‐associated ...
Elias Haj‐Yehia   +6 more
wiley   +1 more source

Analysis of Peripheral T Cell Profiling and Plasma Proteomics in Advanced NSCLC Patients Treated With Atezolizumab

open access: yesCancer Science, EarlyView.
This study found immune markers that may predict how well patients with advanced lung cancer respond to atezolizumab. Higher levels of certain T cells were linked to better survival. Specific patterns suggested a worse prognosis for some patients. ABSTRACT We investigated immunologic biomarkers that predict outcomes of patients with previously treated ...
Atsuto Mouri   +24 more
wiley   +1 more source

Peritoneal carcinomatosis in metastatic Non-Small Cell Lung Cancer: review of the literature. [PDF]

open access: yesCancer Metastasis Rev
Meriggi F   +5 more
europepmc   +1 more source

KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC

open access: green
Tubita A   +12 more
openalex   +1 more source

Home - About - Disclaimer - Privacy